Carvedilol
Product Images NDC 43353-132

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 43353-132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 3.125mg (43353 132)

Label for Carvedilol tablets, 3.125 mg strength, containing 60 tablets. The label indicates storage instructions and that it is repackaged by Aphena Pharma Solutions - Tennessee, LLC. It also lists the original manufacturer as Mylan Pharmaceuticals Inc., Morgantown, WV. The label includes NDC number 43353-0132-53 and states the product is for RX only.*

FDA Label Image

Bottle Label 25mg (43353 133)

Carvedilol 25 mg tablet label indicating a package of 180 tablets. The label includes the drug name, strength, quantity, manufacturer Mylan Pharmaceuticals Inc., Morgantown, WV, and repackager Aphena Pharma Solutions - Tennessee, LLC. It also notes storage instructions between 20-25 degrees Celsius and states RX only.*

FDA Label Image

Bottle Label 6.25mg (43353 156)

Carvedilol 6.25 mg label for 90 tablets, repackaged by Aphena Pharma Solutions - Tennessee, LLC. The label shows storage instructions, manufacturer Mylan Pharmaceuticals Inc. in Morgantown, WV, and includes the NDC number 43353-0156-60. The product is RX Only and dispensed in a tight light-resistant container.*

FDA Label Image

Bottle Label 12.5mg (43353 160)

Carvedilol 12.5 mg tablet bottle label showing quantity of 120 tablets. The label includes storage instructions, manufacturer Mylan Pharmaceuticals Inc., and repackager Aphena Pharma Solutions - Tennessee, LLC. The product is for prescription use only with an NDC number 43353-0160-70.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Carvedilol Structural Formula (Cb677d92 9518 47a0 85ad Fefb503f3e06 01)

Chemical structure diagram of the active ingredient Carvedilol, showing its molecular framework with labeled atom groups and bonds.*

FDA Label Image

Figure 1. Survival Analysis For Capricorn (intent-to-treat) (Cb677d92 9518 47a0 85ad Fefb503f3e06 02)

A Kaplan-Meier curve comparing percent mortality over 24 months between Carvedilol and placebo groups. The chart shows cumulative mortality on the y-axis and time in months on the x-axis, with Carvedilol group consistently below placebo, indicating lower mortality. A p-value of 0.03 is noted, reflecting statistical significance.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Capricorn (Cb677d92 9518 47a0 85ad Fefb503f3e06 03)

A forest plot showing hazard ratios for various patient subgroups related to Carvedilol treatment outcomes. Subgroups include age, gender, timing of randomization post-myocardial infarction, prior beta-blocker use, Killip classification, thrombolytic therapy, percutaneous transluminal coronary angioplasty, congestive heart failure status, diuretic use, presence of angina, hypertension, diabetes, heart rate, and systolic blood pressure. The plot provides visual hazard ratios with confidence intervals for each category.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.